Are study dropouts different from completers?
References (19)
- et al.
A Double-Blind Comparison of Paroxetine with Imipramine in the Long-term Treatment of Depression
J Clin Psychopharmacol
(1993) Compliance with lithium regimens in outpatient treatment of bipolar affective disorders
J Compliance Health Care
(1986)- et al.
Proposed hostility and pharasaicvirtue scales for the MMPI
J Appl Psychol
(1954) - et al.
A comparison of venlafaxine, trazodone, and placebo in major depression
J Clin Psychopharmacol
(1994) Therapeutic Considerations in Treating Depression in the Elderly
J Clin Psychiatry
(1994)- et al.
Quality of life changes after fluoxetine treatment of depression
- et al.
Paroxetine in the treatment of depression: A comparison with imipramine and placebo
J Clin Psychiatry
(1992) - et al.
Double-blind comparison of bupropion and fluoxetine in depressed outpatients
J Clin Psychiatry
(1991) ECDEU Assessment Manual for Psychopharmacology
Cited by (28)
Treatment attitudes and adherence of psychiatric patients with major depressive disorder: A five-year prospective study
2010, Journal of Affective DisordersCitation Excerpt :We did not detect a significant association between extroversion, neuroticism and adherence. One secondary care study described an association between lower rates of narcissistic–histrionic personality disorders and better adherence (Tedlow et al., 2002; Tedlow et al., 1996). In general, personality pathology is thought of as behaviour patterns with limited adaptive capability (American Psychiatric Association, 2000).
Anxiety sensitivity: A unique predictor of dropout among inner-city heroin and crack/cocaine users in residential substance use treatment
2008, Behaviour Research and TherapyCitation Excerpt :To the extent that individuals with high AS do not have adequate psychological resources to successfully cope with such aversive events, they may be more likely to prematurely terminate substance use treatment. This research is supported by a study suggesting that AS, relative to other predictors, may have utility in identifying patients who drop out of antidepressant trials, perhaps because of a heightened sensitivity to the side effects from these medications (Tedlow et al., 1996). Likewise, data suggest that heightened AS is a risk factor for early lapse during smoking cessation (Brown et al., 2001), and the degree of change in AS has been a significant predictor of relapse among those discontinuing use of benzodiazepines (Bruce, Spiegel, Gregg, & Nuzzarello, 1995).
Comparing anxiety disorders and anxiety-related traits in bipolar disorder and unipolar depression
2003, Journal of Psychiatric ResearchEarly drop-outs, late drop-outs and completers: Differences in the continuation phase of a clinical trial
2002, Progress in Neuro-Psychopharmacology and Biological PsychiatryWhat predicts attrition in second step medication treatments for depression?: A STAR D Report
2009, International Journal of Neuropsychopharmacology
This work was supported in part by NIMH grant RO1 MH48483-01.